Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection

World Journal of Gastroenterology

Volumn 10, Issue 21, 2004, Pages 3215-3217

  Li, Xiao Mao ^a   Shi, Min Feng ^b   Yang, Yue Bo ^a   Shi, Zhong Jie ^a   Hou, Hong Ying ^a   Shen, Hui Min ^a   Teng, Ben Qi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; INFLAMMATION; INTRAUTERINE INFECTION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MOTHER; NEWBORN; NEWBORN DISEASE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RASH; RHINOSCLEROMA; RIGOR; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY; VIRUS INHIBITION;

EID: 7044239650     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i21.3215     Document Type: Article

References (16)

1. Hepatitis B vaccination-United States, 1982-2002. Morb Mortal Wkly Rep 2002; 51: 549-552
2. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 2002; 359: 1488-1489
3. Gerdts V, Babiuk LA, van Drunen Littel-van den Hurk, Griebel PJ. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat Med 2000; 6: 929-932
4. Chen DS. Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15(Suppl): E7-10
5. Mast EE, Mahoney FJ, Alter MJ, Margolis HS. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine 1998; 16(Suppl): S48-51
6. Yu XL, Chen CH, Zhong M. Reasons of failure in blocking mother-infant transmission of HBV by using vaccine and related strategies. Zhonghua Huli Zazhi 1997; 32: 69-71
7. Hamdani-Belghiti S, Bouazzaou NL. Mother-child transmission of hepatitis B virus. State of the problem and prevention. Arch Pediatr 2000; 7: 879-882
8. Li XM, Liu SL, Li X, Huang HJ, Lu JX, Gao ZL. The relative study of hepatitise B virus DNA in maternal blood, umbilical blood and breastmilk. Acad J SUMS 2000; 21: 233-235
9. Yang YB, Teng BQ, Li XM, Lin CS, Hou HY, Shen HM. The application of PCR in the test of HBV DNA quantitation. J Sun Yat Sen University 2003; 24: 20-23
10. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998; 27: 100-106
11. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9: 1501-1503
12. Zhu Q, Lu Q, Gu X, Xu H, Duan S. A preliminary study on interruption of HBV transmission in uterus. Chin Med J 1997; 110 145-147
13. Yue YF, Yang XJ, Zhang SL, Han XB. Clinical study on the prevention of HBV transmission from mother to infant by injection of HBIG in pregnant women with HBsAg. Chin J Practical Gynecol Obstet 1999; 15: 547-548
14. Rumi MA, Begum K, Hassan MS, Hasan SM, Azam MG, Hasan KN, Shirin M, Khan AK. Detection of hepatitis B surface antigen in pregnant women amending a public hospital for delivery: implication for vaccination strategy in Bangladesh. Am J Trop Med Hyg 1998; 59 318-322
15. Suga M, Shibata K, Kodama T, Arima K, Yamada S, Yachi A. A case of HBs antigen negative fulminant hepatitis with IgM antibody to hepatitis B core antigen persisting more than seven years. Gastroenterol Jpn 1991; 26: 661-665
16. Wang JS, Zhu QR. Infection of the fetus with hepatitis B e antigen via the placenta. Lancet 2000; 355: 989